DRC12
gene geneOn this page
Also known as LOC283152
Summary
DRC12 (dynein regulatory complex subunit 12 homolog, HGNC:27446) is a protein-coding gene on chromosome 11q23.3, encoding Dynein regulatory complex protein 12 (Q494R4). Component of the nexin-dynein regulatory complex (N-DRC), a key regulator of ciliary/flagellar motility which maintains the alignment and integrity of the distal axoneme and regulates microtubule sliding in motile axonemes.
Enables identical protein binding activity. Predicted to be located in cytoplasm; cytoskeleton; and motile cilium.
Source: NCBI Gene 283152 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 31 total — 1 pathogenic
- MANE Select transcript:
NM_001145018
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:27446 |
| Approved symbol | DRC12 |
| Name | dynein regulatory complex subunit 12 homolog |
| Location | 11q23.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | LOC283152 |
| Ensembl gene | ENSG00000248712 |
| Ensembl biotype | protein_coding |
| Entrez | 283152 |
Gene structure
Transcript identifiers
Ensembl transcripts: 13 — 11 protein_coding, 2 retained_intron
ENST00000375140, ENST00000415318, ENST00000447948, ENST00000503566, ENST00000902924, ENST00000902925, ENST00000902926, ENST00000902927, ENST00000927899, ENST00000927900, ENST00000927901, ENST00000927902, ENST00000927903
RefSeq mRNA: 1 — MANE Select: NM_001145018
NM_001145018
CCDS: CCDS44753
Canonical transcript exons
ENST00000503566 — 7 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002086084 | 119190254 | 119190452 |
| ENSE00002295360 | 119193151 | 119193243 |
| ENSE00002317507 | 119193766 | 119193885 |
| ENSE00003501452 | 119194923 | 119194994 |
| ENSE00003611415 | 119190710 | 119190840 |
| ENSE00003657704 | 119195424 | 119195499 |
| ENSE00003932052 | 119195799 | 119195841 |
Expression profiles
Bgee: expression breadth ubiquitous, 167 present calls, max score 94.87.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.3145 / max 14.5930, expressed in 175 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 122695 | 0.3145 | 175 |
Top tissues by expression
253 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right uterine tube | UBERON:0001302 | 94.87 | gold quality |
| bronchial epithelial cell | CL:0002328 | 91.65 | gold quality |
| bronchus | UBERON:0002185 | 89.98 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 86.56 | gold quality |
| oviduct epithelium | UBERON:0004804 | 81.11 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 81.04 | gold quality |
| fallopian tube | UBERON:0003889 | 78.29 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 77.33 | gold quality |
| adenohypophysis | UBERON:0002196 | 75.89 | gold quality |
| pituitary gland | UBERON:0000007 | 75.40 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 75.04 | silver quality |
| left testis | UBERON:0004533 | 74.42 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 73.92 | silver quality |
| right testis | UBERON:0004534 | 73.74 | gold quality |
| nasal cavity mucosa | UBERON:0001826 | 73.04 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 72.67 | gold quality |
| testis | UBERON:0000473 | 72.29 | gold quality |
| granulocyte | CL:0000094 | 72.27 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 71.86 | gold quality |
| leukocyte | CL:0000738 | 70.91 | gold quality |
| monocyte | CL:0000576 | 70.84 | gold quality |
| right lung | UBERON:0002167 | 70.24 | gold quality |
| buccal mucosa cell | CL:0002336 | 69.47 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 69.26 | gold quality |
| tibial artery | UBERON:0007610 | 67.95 | gold quality |
| popliteal artery | UBERON:0002250 | 67.93 | gold quality |
| omental fat pad | UBERON:0010414 | 67.35 | gold quality |
| peritoneum | UBERON:0002358 | 67.34 | gold quality |
| left uterine tube | UBERON:0001303 | 67.32 | gold quality |
| hypothalamus | UBERON:0001898 | 67.30 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 3.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-CURD-114 | yes | 61.74 |
| E-HCAD-1 | yes | 26.53 |
| E-ANND-3 | yes | 9.27 |
Regulation
Is transcription factor: no
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Ccdc153 | ENSMUSG00000070306 |
| rattus_norvegicus | Drc12 | ENSRNOG00000039086 |
Protein
Protein identifiers
Dynein regulatory complex protein 12 — Q494R4 (reviewed: Q494R4)
Alternative names: Coiled-coil domain-containing protein 153, Dynein regulatory complex subunit 12 homolog
All UniProt accessions (1): Q494R4
UniProt curated annotations — full annotation on UniProt →
Function. Component of the nexin-dynein regulatory complex (N-DRC), a key regulator of ciliary/flagellar motility which maintains the alignment and integrity of the distal axoneme and regulates microtubule sliding in motile axonemes.
Subunit / interactions. Component of the nexin-dynein regulatory complex (N-DRC).
Subcellular location. Cytoplasm. Cytoskeleton. Flagellum axoneme.
Similarity. Belongs to the DRC12 family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q494R4-1 | 1 | yes |
| Q494R4-2 | 2 |
RefSeq proteins (1): NP_001138490* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR033585 | DRC12-like | Family |
UniProt features (7 total): region of interest 2, chain 1, coiled-coil region 1, compositionally biased region 1, splice variant 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q494R4-F1 | 88.66 | 0.74 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 40 (showing top):
GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8_TCELL_IFNAR_KO_UP, NUYTTEN_EZH2_TARGETS_DN, DODD_NASOPHARYNGEAL_CARCINOMA_DN, PRKDC_TARGET_GENES, ZNF350_TARGET_GENES, ZNF766_TARGET_GENES, GSE13485_DAY3_VS_DAY7_YF17D_VACCINE_PBMC_UP, GSE14350_IL2RB_KO_VS_WT_TEFF_DN, DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_RESPIRATORY_CILIATED_CELLS, DESCARTES_MAIN_FETAL_CILIATED_EPITHELIAL_CELLS, DESCARTES_FETAL_LUNG_CILIATED_EPITHELIAL_CELLS, OSMAN_BLOOD_CHAD63_KH_AGE_18_50YO_HIGH_DOSE_SUBJECTS_24HR_DN, TRAVAGLINI_LUNG_CILIATED_CELL, TRAVAGLINI_LUNG_PROXIMAL_CILIATED_CELL, HE_LIM_SUN_FETAL_LUNG_C0_LATE_MESOTHELIAL_CELL
GO Biological Process (0):
GO Molecular Function (2): identical protein binding (GO:0042802), protein binding (GO:0005515)
GO Cellular Component (5): cytoplasm (GO:0005737), cytoskeleton (GO:0005856), cilium (GO:0005929), motile cilium (GO:0031514), cell projection (GO:0042995)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 2 |
| protein binding | 1 |
| binding | 1 |
| intracellular anatomical structure | 1 |
| intracellular membraneless organelle | 1 |
| intraciliary transport particle | 1 |
| membrane-bounded organelle | 1 |
| plasma membrane bounded cell projection | 1 |
| cilium | 1 |
Protein interactions and networks
STRING
168 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| DRC12 | CFAP263 | Q9H0I3 | 626 |
| DRC12 | LYPD2 | Q6UXB3 | 577 |
| DRC12 | MLF1 | P58340 | 572 |
| DRC12 | DAPL1 | A0PJW8 | 557 |
| DRC12 | LZTFL1 | Q9NQ48 | 524 |
| DRC12 | FOXI1 | Q12951 | 519 |
| DRC12 | ASCL3 | Q9NQ33 | 483 |
| DRC12 | KRT4 | P19013 | 438 |
| DRC12 | TPPP3 | Q9BW30 | 414 |
| DRC12 | SCGB3A2 | Q96PL1 | 397 |
| DRC12 | CYP2F1 | P24903 | 369 |
| DRC12 | RNF26 | Q9BY78 | 349 |
| DRC12 | CFAP300 | Q9BRQ4 | 348 |
| DRC12 | TXLNB | Q8N3L3 | 336 |
| DRC12 | TMEM212 | A6NML5 | 306 |
IntAct
20 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| GORASP2 | DRC12 | psi-mi:“MI:0915”(physical association) | 0.670 |
| DRC12 | GORASP2 | psi-mi:“MI:0915”(physical association) | 0.670 |
| DRC12 | NECAB2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| DRC12 | DDIT3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NUP62 | DRC12 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CDR2 | DRC12 | psi-mi:“MI:0915”(physical association) | 0.560 |
| DRC12 | DTNBP1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NECAB2 | DRC12 | psi-mi:“MI:0915”(physical association) | 0.560 |
| DRC12 | CDR2 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (21): CCDC153 (Two-hybrid), CCDC153 (Two-hybrid), CCDC153 (Two-hybrid), CCDC153 (Two-hybrid), CCDC153 (Two-hybrid), CCDC153 (Two-hybrid), CCDC153 (Two-hybrid), CCDC153 (Two-hybrid), CCDC153 (Two-hybrid), CCDC153 (Two-hybrid), CCDC153 (Two-hybrid), CCDC153 (Two-hybrid), CCDC153 (Two-hybrid), CCDC153 (Two-hybrid), CCDC153 (Two-hybrid)
ESM2 similar proteins: A1A5D9, A1L3T7, A4FV37, A6NC98, A6NJZ7, A6NNM3, O15049, P0C7N4, P0CW27, P58660, Q0P5D1, Q1HGE8, Q2NL23, Q3LUD3, Q3UPH7, Q494R4, Q4QRL3, Q5JYT7, Q5ND29, Q5XIS1, Q64697, Q6QZQ4, Q6UXH0, Q6ZS72, Q7Z6P3, Q8BLS7, Q8C2K5, Q8C7U1, Q8CB62, Q8CB87, Q8CHW5, Q8N137, Q8R1L8, Q8TE77, Q8TER5, Q91VJ2, Q969G5, Q96EN9, Q96FF7, Q96LX7
Diamond homologs: A8KB59, Q0P5D1, Q494R4, P0C7Q1, Q5FVL4
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
31 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 24 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 3244710 | NC_000011.9:g.(?118007742)(119170491_?)del | Pathogenic |
SpliceAI
1107 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:119190479:A:T | acceptor_gain | 1.0000 |
| 11:119190708:A:AC | donor_gain | 1.0000 |
| 11:119190709:C:CC | donor_gain | 1.0000 |
| 11:119193275:C:T | acceptor_gain | 1.0000 |
| 11:119193275:CAGGT:C | acceptor_gain | 1.0000 |
| 11:119193276:A:T | acceptor_gain | 1.0000 |
| 11:119193279:T:TC | acceptor_gain | 1.0000 |
| 11:119190478:C:CT | acceptor_gain | 0.9900 |
| 11:119190702:GTGCT:G | donor_loss | 0.9900 |
| 11:119190703:TGCTT:T | donor_loss | 0.9900 |
| 11:119190704:GCTT:G | donor_loss | 0.9900 |
| 11:119190705:CT:C | donor_loss | 0.9900 |
| 11:119190706:TT:T | donor_loss | 0.9900 |
| 11:119190707:T:TG | donor_loss | 0.9900 |
| 11:119190708:A:AG | donor_loss | 0.9900 |
| 11:119190709:C:T | donor_loss | 0.9900 |
| 11:119190720:T:A | donor_gain | 0.9900 |
| 11:119190730:T:TA | donor_gain | 0.9900 |
| 11:119190836:TGCCT:T | acceptor_gain | 0.9900 |
| 11:119190839:CT:C | acceptor_gain | 0.9900 |
| 11:119190841:C:CC | acceptor_gain | 0.9900 |
| 11:119190848:C:CT | acceptor_gain | 0.9900 |
| 11:119190849:A:T | acceptor_gain | 0.9900 |
| 11:119190852:C:CT | acceptor_gain | 0.9900 |
| 11:119190853:A:T | acceptor_gain | 0.9900 |
| 11:119190856:A:C | acceptor_gain | 0.9900 |
| 11:119193150:CCTAG:C | donor_gain | 0.9900 |
| 11:119193274:CCAGG:C | acceptor_gain | 0.9900 |
| 11:119193279:T:C | acceptor_gain | 0.9900 |
| 11:119193285:A:AC | acceptor_gain | 0.9900 |
AlphaMissense
1364 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 11:119193239:C:A | M87I | 0.746 |
| 11:119193239:C:G | M87I | 0.746 |
| 11:119193239:C:T | M87I | 0.746 |
| 11:119190402:C:A | W177C | 0.720 |
| 11:119190402:C:G | W177C | 0.720 |
| 11:119194949:T:A | E37V | 0.710 |
| 11:119190447:A:C | S162R | 0.696 |
| 11:119190447:A:T | S162R | 0.696 |
| 11:119190449:T:G | S162R | 0.696 |
| 11:119193859:C:G | A55P | 0.695 |
| 11:119193240:A:G | M87T | 0.649 |
| 11:119193234:C:G | R89P | 0.608 |
| 11:119190717:A:G | I158T | 0.601 |
| 11:119190737:C:A | M151I | 0.600 |
| 11:119190737:C:G | M151I | 0.600 |
| 11:119190737:C:T | M151I | 0.600 |
| 11:119193774:A:T | I83K | 0.596 |
| 11:119190348:A:C | F195L | 0.581 |
| 11:119190348:A:T | F195L | 0.581 |
| 11:119190350:A:G | F195L | 0.581 |
| 11:119193864:C:G | R53P | 0.570 |
dbSNP variants (sampled 300 via entrez): RS1000176398 (11:119190517 T>C), RS1000483488 (11:119192995 G>A,T), RS1000858558 (11:119197753 C>G), RS1001570765 (11:119193738 C>T), RS1002195650 (11:119192461 T>C), RS1003318057 (11:119195311 A>G), RS1004265659 (11:119195889 C>A), RS1004494468 (11:119195684 C>G), RS1004800970 (11:119192417 A>T), RS1005092152 (11:119194376 G>C), RS1005332819 (11:119195207 G>C), RS1005758300 (11:119197033 A>G,T), RS1005869242 (11:119191084 C>T), RS1006668192 (11:119189786 T>A,C), RS1006747649 (11:119193958 C>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004607_34 | Plateletcrit | 1.000000e-57 |
| GCST90002388_546 | Lymphocyte count | 9.000000e-15 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0007985 | platelet crit |
| EFO:0004587 | lymphocyte count |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
17 total (human), top 17 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Air Pollutants | decreases expression, increases abundance, increases expression | 2 |
| propionaldehyde | increases expression | 1 |
| butyraldehyde | increases expression | 1 |
| pentanal | increases expression | 1 |
| perfluorooctane sulfonic acid | decreases expression | 1 |
| 2-palmitoylglycerol | increases expression | 1 |
| entinostat | increases expression | 1 |
| Glyphosate | increases expression | 1 |
| Aldehydes | increases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Estradiol | decreases expression | 1 |
| Silicon Dioxide | decreases expression | 1 |
| Smoke | increases abundance, increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Urethane | decreases expression | 1 |
| 2,4-Dichlorophenoxyacetic Acid | increases expression | 1 |
| Particulate Matter | decreases expression, increases abundance | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.